Ulcerative colitis remission-recurrence study
Part of Digestive system clinical trials.
This trial studies people with ulcerative colitis who are in a 'remission-recurrence' state, meaning their symptoms come and go. It aims to better understand this pattern and may help guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ulcerative colitis through tests like imaging, colonoscopy, or lab work.
- You have symptoms that suggest your colitis is in a cycle of getting better and then worse.
- Your doctor has run a full set of lab tests to check your health.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients with Crohn's disease or ulcerative colitis to see how their intestine heals after surgery. It looks for signs that can predict whether inflammation will return or complications will happen.
This trial uses a gentle ultrasound scan (on the outside of the body) to see how well treatment is working during a moderate to severe flare of ulcerative colitis. It aims to find out if this painless test can predict recovery and help guide care without needing a telescope exam (endoscopy).
This trial tests a new treatment for people with ulcerative colitis (UC) whose disease is active despite taking only mesalamine or sulfasalazine. It aims to find a therapy that can reduce inflammation and improve symptoms.
This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.
This study tests a new medication called BI 3032950 for people with ulcerative colitis who have already tried other advanced treatments (biologics or targeted therapies) that didn't work well enough or caused problems. The goal is to see if the new drug is safe and helps control inflammation in the colon.
This trial tests whether a prebiotic supplement can improve symptoms of ulcerative colitis. It may be a good option for people with active symptoms who are already on stable medications.
Hear when a new Ulcerative Colitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.